{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T08:30:23Z","timestamp":1773736223570,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.carrev.2015.03.008","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T05:05:50Z","timestamp":1428728750000},"page":"237-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Composite outcomes in 2.25-mm drug eluting stents: a systematic review"],"prefix":"10.1016","volume":"16","author":[{"given":"Justin Z.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5798-1132","authenticated-orcid":false,"given":"Gilbert","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"See Wei","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uday","family":"Kanakadandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. David","family":"Fortuin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Lassar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwan S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2015.03.008_bb0005","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.292.22.2727","article-title":"Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial","volume":"292","author":"Ardissino","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2015.03.008_bb0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijcard.2006.05.018","volume":"117","author":"Biondi-Zoccai","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2015.03.008_bb0015","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/01.CIR.98.18.1875","article-title":"Vessel size and long-term outcome after coronary stent placement","volume":"98","author":"Elezi","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2015.03.008_bb0020","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/01.CIR.90.3.1239","article-title":"Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty","volume":"90","author":"Foley","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2015.03.008_bb0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0735-1097(99)00181-3","article-title":"Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization","volume":"34","author":"Schunkert","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.03.008_bb0030","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0735-1097(98)00444-6","article-title":"Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels","volume":"32","author":"Akiyama","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.03.008_bb0035","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2015.03.008_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2015.03.008_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijcard.2011.04.016","article-title":"Drug-eluting stents perform better than bare metal stents in small coronary vessels: a meta-analysis of randomised and observational clinical studies with mid-term follow up","volume":"161","author":"Cortese","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2015.03.008_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.carrev.2009.04.007","article-title":"Percutaneous coronary intervention for small vessel coronary artery disease","volume":"11","author":"Biondi-Zoccai","year":"2010","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2015.03.008_bb0055","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.carrev.2015.03.008_bb0060","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2015.03.008_bb0065","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2015.03.008_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.carrev.2015.03.008_bb0075","first-page":"546","article-title":"The Xience Nano everolimus eluting coronary stent system for the treatment of small coronary arteries: the SPIRIT small vessel trial","volume":"80","author":"Cannon","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2015.03.008_bb0080","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.amjcard.2003.11.037","article-title":"Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry)","volume":"93","author":"Lemos","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2015.03.008_bb0085","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.amjcard.2006.06.047","article-title":"Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial","volume":"98","author":"Moses","year":"2006","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2015.03.008_bb0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MCA.0b013e32835b3932","article-title":"Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS small vessel, and TAXUS ATLAS long lesion clinical trials of the TAXUS Liberte paclitaxel-eluting stent in de-novo coronary artery lesions","volume":"24","author":"Ormiston","year":"2013","journal-title":"Coronary Artery Disease"},{"key":"10.1016\/j.carrev.2015.03.008_bb0095","first-page":"94","article-title":"Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries","volume":"69","author":"Tanimoto","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2015.03.008_bb0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jcin.2008.09.007","article-title":"Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut Taxus Liberte stent: 1-year results from the TAXUS ATLAS program","volume":"1","author":"Turco","year":"2008","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.carrev.2015.03.008_bb0105","first-page":"207","article-title":"Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions","volume":"85","author":"Teirstein","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2015.03.008_bb0110","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.294.10.1215","article-title":"Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial","volume":"294","author":"Stone","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.carrev.2015.03.008_bb0115","first-page":"17","article-title":"Performance of the Resolute zotarolimus-eluting stent in small vessels","volume":"84","author":"Caputo","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2015.03.008_bb0120","doi-asserted-by":"crossref","first-page":"1019.e1011","DOI":"10.1016\/j.ahj.2006.02.025","article-title":"Sirolimus-eluting coronary stents in small vessels","volume":"151","author":"Meier","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2015.03.008_bb0125","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1161\/CIRCULATIONAHA.104.513952","article-title":"Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison","volume":"111","author":"Mauri","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2015.03.008_bb0130","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jacc.2004.11.063","article-title":"Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial","volume":"45","author":"Ellis","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.03.008_bb0135","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/eurheartj\/ehi116","article-title":"Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials","volume":"26","author":"Agostoni","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2015.03.008_bb0140","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.amjcard.2010.10.069","article-title":"Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III trial)","volume":"107","author":"Applegate","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2015.03.008_bb0145","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/eurheartj\/ehi721","article-title":"Intracoronary drug-eluting stenting to abrogate restenosis in small arteries study (ISAR-SMART 3) Study Investigators. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels","volume":"27","author":"Mehilli","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2015.03.008_bb0150","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2007.06.015","article-title":"Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial","volume":"50","author":"Togni","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.03.008_bb0155","first-page":"821","article-title":"Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries","volume":"69","author":"Lee","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2015.03.008_bb0160","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jacc.2011.03.005","article-title":"Clinical evaluation of the Resolute zotarolimus-eluting coronary stent system in the treatment of de novo lesions in native coronary arteries: the RESOLUTE US clinical trial","volume":"57","author":"Yeung","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.03.008_bb0165","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(11)60395-4","article-title":"RESOLUTE All Comers Investigators Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial","volume":"377","author":"Silber","year":"2011","journal-title":"Lancet"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838915000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838915000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:10:41Z","timestamp":1761559841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838915000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1553838915000974"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2015.03.008","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Composite outcomes in 2.25-mm drug eluting stents: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2015.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}